Literature DB >> 12057873

Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC.

Yasuo Sekine1, Mehrdad Behnia, Takehiko Fujisawa.   

Abstract

PURPOSE: The purpose of our study was to determine the incidence of various types of postoperative pulmonary complications and to evaluate the impact of chronic obstructive pulmonary disease (COPD) on the long-term survival of patients with non-small cell lung cancer (NSCLC) undergoing pulmonary resection.
METHODS: We performed a retrospective chart review of 244 patients who had undergone lung resection for NSCLC at Indiana University. COPD, defined as predicted forced expiratory volume in 1 s (FEV1)< or =70% and FEV1/FVC< or =70%, was determined based on preoperative pulmonary function testing in 78 of 244 patients (COPD group). The remaining 166 patients were classified as non-COPD. The incidence of postoperative complications, which included air leak of > or=10 days, atelectasis, pneumothorax, pneumonia, bronchopleural fistula, empyema, acute respiratory distress syndrome, mechanical ventilation of > or =7 days, and outpatient oxygen supplementation were compared between the two groups. Long-term survival and mortality due to respiratory failure were analyzed between the two groups using the Kaplan-Meier method and log rank test.
RESULTS: All of the above-stated postoperative pulmonary complications occurred more frequently in the COPD than in the non-COPD patients (all P<0.01). The overall 5-year survival rate was 36.2% in the COPD and 41.2% in the non-COPD patients (P=0.1023). Five-year cancer related survival was 43.2% in the COPD and 47.7% in the non-COPD patients (P=0.357). There was no significant difference in survival among patients with different stages of lung cancer. However, the intercurrent survival, which is associated with non-cancer related death, was 60.1% in patients with COPD and 86.2% in patients without COPD at 5 years (P<0.0001). The major cause of non-cancer related death in the COPD group was respiratory failure (P=0.0008).
CONCLUSION: The presence of COPD is an acceptable predictor of postoperative pulmonary complications in patients with NSCLC. COPD is also a significant risk factor for development of respiratory-related complications, which may explain the poor long-term survival in these patients.

Entities:  

Mesh:

Year:  2002        PMID: 12057873     DOI: 10.1016/s0169-5002(02)00014-4

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  51 in total

1.  Inspiratory capacity as a preoperative assessment of patients undergoing thoracic surgery.

Authors:  Masaki Matsuo; Naozumi Hashimoto; Noriyasu Usami; Kazuyoshi Imaizumi; Kenji Wakai; Tsutomu Kawabe; Kohei Yokoi; Yoshinori Hasegawa
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-03

2.  Diffusing capacity predicts long-term survival after lung resection for cancer.

Authors:  Mark K Ferguson; James J Dignam; Juned Siddique; Wickii T Vigneswaran; Amy D Celauro
Journal:  Eur J Cardiothorac Surg       Date:  2012-02-24       Impact factor: 4.191

3.  Risk quantification for pulmonary complications after lung cancer surgery.

Authors:  Yasuo Sekine; Hidemi Suzuki; Takahiro Nakajima; Kazuhiro Yasufuku; Shigetoshi Yoshida
Journal:  Surg Today       Date:  2010-11-03       Impact factor: 2.549

Review 4.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

5.  Efficacy of perioperative administration of long-acting bronchodilator on postoperative pulmonary function and quality of life in lung cancer patients with chronic obstructive pulmonary disease. Preliminary results of a randomized control study.

Authors:  Hidemi Suzuki; Yasuo Sekine; Shigetoshi Yoshida; Makoto Suzuki; Kiyoshi Shibuya; Yuichi Takiguchi; Koichiro Tatsumi; Ichiro Yoshino
Journal:  Surg Today       Date:  2010-09-25       Impact factor: 2.549

6.  Obstructive lung disease in smokers and never smokers: further insights in patient-related approach in lung cancer understanding.

Authors:  Marco Alifano
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

7.  Forced vital capacity predicts long-term survival for curative-resected NSCLC.

Authors:  Xi Guo; Hongxin Cao; Jun Xu; Jianyu Yu; Chunlong Zheng; Long Meng; Jiajun Du
Journal:  Med Oncol       Date:  2014-08-07       Impact factor: 3.064

8.  Prognosis of smokers following resection of pathological stage I non-small-cell lung carcinoma.

Authors:  Noriyoshi Sawabata; Shinichiro Miyoshi; Akihide Matsumura; Mitsunori Ohta; Hajime Maeda; Hirofumi Sueki; Masanobu Hayakawa; Meinoshin Okumura; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-10

9.  The impact of chronic obstructive pulmonary disease and obesity on length of stay and cost of spine surgery.

Authors:  M Sami Walid; Nadezhda V Zaytseva
Journal:  Indian J Orthop       Date:  2010-10       Impact factor: 1.251

Review 10.  Changing the burden of COPD mortality.

Authors:  David M Mannino; Victor A Kiriz
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.